Skip to main content
Erschienen in: Head and Neck Pathology 1/2022

21.03.2022 | Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base

verfasst von: Lester D. R. Thompson, Justin A. Bishop

Erschienen in: Head and Neck Pathology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

The World Health Organization Classification of Head and Neck Tumours recently published the 5th edition. There are new entities, emerging entities, and significant updates to the taxonomy and characterization of tumor and tumor-like lesions, specifically in this article as it relates to nasal cavity, paranasal sinuses and skull base. Importantly, the number of diagnostic entries has been reduced by creating category-specific chapters for soft tissue, hematolymphoid, melanocytic, neuroectodermal, and metastatic tumors. Bone and salivary gland tumors are also not separately reported in the sinonasal tract, but included in the jaw and salivary gland sections, respectively. Repetition of characteristic entities in each anatomic site was also reduced, instead highlighting only the unique features in each anatomic site. Two new entities (SWI/SNF complex-deficient sinonasal carcinomas and HPV-related multiphenotypic sinonasal carcinoma) will be highlighted in this review, with a discussion of several emerging entities. There is a short description of updated information for all 24 diagnostic entities included in this edition to allow the reader a snapshot of current state of knowledge, but to encourage more investigation and further broaden understanding of these diverse and rare entities.
Literatur
1.
Zurück zum Zitat Bishop JA, Loney EL, Thompson LDR. Nasal cavity, paranasal sinuses, and skull base tumours. In: Board WCTE, editor. Head and neck tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2022. Bishop JA, Loney EL, Thompson LDR. Nasal cavity, paranasal sinuses, and skull base tumours. In: Board WCTE, editor. Head and neck tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2022.
2.
Zurück zum Zitat Ozolek JA, Hunt JL. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. Am J Surg Pathol. 2006;30:1576–80.PubMedCrossRef Ozolek JA, Hunt JL. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. Am J Surg Pathol. 2006;30:1576–80.PubMedCrossRef
3.
Zurück zum Zitat Baneckova M, Michal M, Laco J, et al. Immunohistochemical and genetic analysis of respiratory epithelial adenomatoid hamartomas and seromucinous hamartomas: are they precursor lesions to sinonasal low-grade tubulopapillary adenocarcinomas? Hum Pathol. 2020;97:94–102.PubMedCrossRef Baneckova M, Michal M, Laco J, et al. Immunohistochemical and genetic analysis of respiratory epithelial adenomatoid hamartomas and seromucinous hamartomas: are they precursor lesions to sinonasal low-grade tubulopapillary adenocarcinomas? Hum Pathol. 2020;97:94–102.PubMedCrossRef
4.
Zurück zum Zitat Lee JT, Garg R, Brunworth J, Keschner DB, Thompson LD. Sinonasal respiratory epithelial adenomatoid hamartomas: series of 51 cases and literature review. Am J Rhinol Allergy. 2013;27:322–8.PubMedCrossRef Lee JT, Garg R, Brunworth J, Keschner DB, Thompson LD. Sinonasal respiratory epithelial adenomatoid hamartomas: series of 51 cases and literature review. Am J Rhinol Allergy. 2013;27:322–8.PubMedCrossRef
5.
Zurück zum Zitat Daniel A, Wong E, Ho J, Singh N. Chondro-osseous respiratory epithelial adenomatoid hamartoma (COREAH): case report and literature review. Case Rep Otolaryngol. 2019;2019:5247091.PubMedPubMedCentral Daniel A, Wong E, Ho J, Singh N. Chondro-osseous respiratory epithelial adenomatoid hamartoma (COREAH): case report and literature review. Case Rep Otolaryngol. 2019;2019:5247091.PubMedPubMedCentral
6.
Zurück zum Zitat Khan RA, Chernock RD, Lewis JS Jr. Seromucinous hamartoma of the nasal cavity: a report of two cases and review of the literature. Head Neck Pathol. 2011;5:241–7.PubMedPubMedCentralCrossRef Khan RA, Chernock RD, Lewis JS Jr. Seromucinous hamartoma of the nasal cavity: a report of two cases and review of the literature. Head Neck Pathol. 2011;5:241–7.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Weinreb I, Gnepp DR, Laver NM, et al. Seromucinous hamartomas: a clinicopathological study of a sinonasal glandular lesion lacking myoepithelial cells. Histopathology. 2009;54:205–13.PubMedCrossRef Weinreb I, Gnepp DR, Laver NM, et al. Seromucinous hamartomas: a clinicopathological study of a sinonasal glandular lesion lacking myoepithelial cells. Histopathology. 2009;54:205–13.PubMedCrossRef
8.
Zurück zum Zitat Fleming KE, Perez-Ordonez B, Nasser JG, Psooy B, Bullock MJ. Sinonasal seromucinous hamartoma: a review of the literature and a case report with focal myoepithelial cells. Head Neck Pathol. 2012;6:395–9.PubMedPubMedCentralCrossRef Fleming KE, Perez-Ordonez B, Nasser JG, Psooy B, Bullock MJ. Sinonasal seromucinous hamartoma: a review of the literature and a case report with focal myoepithelial cells. Head Neck Pathol. 2012;6:395–9.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Schultz KA, Yang J, Doros L, et al. DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions. Pathol Case Rev. 2014;19:90–100.PubMedPubMedCentralCrossRef Schultz KA, Yang J, Doros L, et al. DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions. Pathol Case Rev. 2014;19:90–100.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Mason KA, Navaratnam A, Theodorakopoulou E, Chokkalingam PG. Nasal Chondromesenchymal Hamartoma (NCMH): a systematic review of the literature with a new case report. J Otolaryngol Head Neck Surg. 2015;44:28.PubMedPubMedCentralCrossRef Mason KA, Navaratnam A, Theodorakopoulou E, Chokkalingam PG. Nasal Chondromesenchymal Hamartoma (NCMH): a systematic review of the literature with a new case report. J Otolaryngol Head Neck Surg. 2015;44:28.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Schultz KAP, Williams GM, Kamihara J, et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res. 2018;24:2251–61.PubMedPubMedCentralCrossRef Schultz KAP, Williams GM, Kamihara J, et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res. 2018;24:2251–61.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Ozolek JA, Carrau R, Barnes EL, Hunt JL. Nasal chondromesenchymal hamartoma in older children and adults: series and immunohistochemical analysis. Arch Pathol Lab Med. 2005;129:1444–50.PubMedCrossRef Ozolek JA, Carrau R, Barnes EL, Hunt JL. Nasal chondromesenchymal hamartoma in older children and adults: series and immunohistochemical analysis. Arch Pathol Lab Med. 2005;129:1444–50.PubMedCrossRef
13.
Zurück zum Zitat Priest JR, Williams GM, Mize WA, Dehner LP, McDermott MB. Nasal chondromesenchymal hamartoma in children with pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry registry. Int J Pediatr Otorhinolaryngol. 2010;74:1240–4.PubMedCrossRef Priest JR, Williams GM, Mize WA, Dehner LP, McDermott MB. Nasal chondromesenchymal hamartoma in children with pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry registry. Int J Pediatr Otorhinolaryngol. 2010;74:1240–4.PubMedCrossRef
14.
Zurück zum Zitat Yang B, Li J, Dong J. MR imaging and CT features of oncocytic papilloma of the sinonasal tract with comparison to inverted papilloma. Br J Radiol. 2018;91:20170957.PubMedPubMedCentralCrossRef Yang B, Li J, Dong J. MR imaging and CT features of oncocytic papilloma of the sinonasal tract with comparison to inverted papilloma. Br J Radiol. 2018;91:20170957.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Rooper LM, Bishop JA, Westra WH. Transcriptionally active high-risk human papillomavirus is not a common etiologic agent in the malignant transformation of inverted schneiderian papillomas. Head Neck Pathol. 2017;11:346.PubMedPubMedCentralCrossRef Rooper LM, Bishop JA, Westra WH. Transcriptionally active high-risk human papillomavirus is not a common etiologic agent in the malignant transformation of inverted schneiderian papillomas. Head Neck Pathol. 2017;11:346.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Mehrad M, Stelow EB, Bishop JA, et al. Transcriptionally active HPV and targetable EGFR mutations in sinonasal inverted papilloma: an association between low-risk HPV, condylomatous morphology, and cancer risk? Am J Surg Pathol. 2020;44:340–6.PubMedCrossRef Mehrad M, Stelow EB, Bishop JA, et al. Transcriptionally active HPV and targetable EGFR mutations in sinonasal inverted papilloma: an association between low-risk HPV, condylomatous morphology, and cancer risk? Am J Surg Pathol. 2020;44:340–6.PubMedCrossRef
17.
Zurück zum Zitat Udager AM, Rolland DCM, McHugh JB, et al. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res. 2015;75:2600–6.PubMedPubMedCentralCrossRef Udager AM, Rolland DCM, McHugh JB, et al. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res. 2015;75:2600–6.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Wang H, Li H, Hu L, et al. EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma. Histopathology. 2019;75:274–81.PubMedCrossRef Wang H, Li H, Hu L, et al. EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma. Histopathology. 2019;75:274–81.PubMedCrossRef
19.
Zurück zum Zitat Udager AM, McHugh JB, Goudsmit CM, et al. Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. Ann Oncol. 2018;29:466–71.PubMedCrossRef Udager AM, McHugh JB, Goudsmit CM, et al. Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. Ann Oncol. 2018;29:466–71.PubMedCrossRef
20.
Zurück zum Zitat Brown NA, Plouffe KR, Yilmaz O, et al. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Mod Pathol. 2021;34:1133–42.PubMedCrossRef Brown NA, Plouffe KR, Yilmaz O, et al. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Mod Pathol. 2021;34:1133–42.PubMedCrossRef
21.
Zurück zum Zitat Rajalingam K, Schreck R, Rapp UR, Albert S. Ras oncogenes and their downstream targets. Biochim Biophys Acta. 2007;1773:1177–95.PubMedCrossRef Rajalingam K, Schreck R, Rapp UR, Albert S. Ras oncogenes and their downstream targets. Biochim Biophys Acta. 2007;1773:1177–95.PubMedCrossRef
22.
Zurück zum Zitat Maisch S, Mueller SK, Traxdorf M, et al. Sinonasal papillomas: a single centre experience on 137 cases with emphasis on malignant transformation and EGFR/KRAS status in “carcinoma ex papilloma.” Ann Diagn Pathol. 2020;46:151504.PubMedCrossRef Maisch S, Mueller SK, Traxdorf M, et al. Sinonasal papillomas: a single centre experience on 137 cases with emphasis on malignant transformation and EGFR/KRAS status in “carcinoma ex papilloma.” Ann Diagn Pathol. 2020;46:151504.PubMedCrossRef
23.
Zurück zum Zitat Buchwald C, Franzmann MB, Jacobsen GK, Lindeberg H. Human papillomavirus (HPV) in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction. Laryngoscope. 1995;105:66–71.PubMedCrossRef Buchwald C, Franzmann MB, Jacobsen GK, Lindeberg H. Human papillomavirus (HPV) in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction. Laryngoscope. 1995;105:66–71.PubMedCrossRef
24.
Zurück zum Zitat Syrjanen K, Syrjanen S. Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis. Laryngoscope. 2013;123:181–92.PubMedCrossRef Syrjanen K, Syrjanen S. Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis. Laryngoscope. 2013;123:181–92.PubMedCrossRef
25.
Zurück zum Zitat Glatre R, De Kermadec H, Alsamad IA, et al. Exophytic sinonasal papillomas and nasal florid papillomatosis: a retrospective study. Head Neck. 2018;40:740–6.PubMedCrossRef Glatre R, De Kermadec H, Alsamad IA, et al. Exophytic sinonasal papillomas and nasal florid papillomatosis: a retrospective study. Head Neck. 2018;40:740–6.PubMedCrossRef
26.
Zurück zum Zitat Mafee MF, Peyman GA, Grisolano JE, et al. Malignant uveal melanoma and simulating lesions: MR imaging evaluation. Radiology. 1986;160:773–80.PubMedCrossRef Mafee MF, Peyman GA, Grisolano JE, et al. Malignant uveal melanoma and simulating lesions: MR imaging evaluation. Radiology. 1986;160:773–80.PubMedCrossRef
27.
Zurück zum Zitat Blumberg JM, Escobar-Stein J, Vining EM, Prasad ML. Low-grade, nonintestinal nonsalivary sinonasal adenocarcinoma associated with an exophytic schneiderian papilloma: a case report. Int J Surg Pathol. 2015;23:662–6.PubMedCrossRef Blumberg JM, Escobar-Stein J, Vining EM, Prasad ML. Low-grade, nonintestinal nonsalivary sinonasal adenocarcinoma associated with an exophytic schneiderian papilloma: a case report. Int J Surg Pathol. 2015;23:662–6.PubMedCrossRef
28.
Zurück zum Zitat Lewis JS Jr, Westra WH, Thompson LD, et al. The sinonasal tract: another potential “Hot Spot” for carcinomas with transcriptionally-active human papillomavirus. Head Neck Pathol. 2013;8:241.PubMedPubMedCentralCrossRef Lewis JS Jr, Westra WH, Thompson LD, et al. The sinonasal tract: another potential “Hot Spot” for carcinomas with transcriptionally-active human papillomavirus. Head Neck Pathol. 2013;8:241.PubMedPubMedCentralCrossRef
29.
30.
Zurück zum Zitat Nudell J, Chiosea S, Thompson LD. Carcinoma ex-Schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature. Head Neck Pathol. 2014;8:269–86.PubMedPubMedCentralCrossRef Nudell J, Chiosea S, Thompson LD. Carcinoma ex-Schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature. Head Neck Pathol. 2014;8:269–86.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat McCuiston A, Bishop JA. Usefulness of NKX2.2 immunohistochemistry for distinguishing Ewing sarcoma from other sinonasal small round blue cell tumors. Head Neck Pathol. 2017;12:89–91.PubMedPubMedCentralCrossRef McCuiston A, Bishop JA. Usefulness of NKX2.2 immunohistochemistry for distinguishing Ewing sarcoma from other sinonasal small round blue cell tumors. Head Neck Pathol. 2017;12:89–91.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015;39:1267–74.PubMedPubMedCentralCrossRef Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015;39:1267–74.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984–91.PubMedPubMedCentralCrossRef Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984–91.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Larque AB, Hakim S, Ordi J, et al. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Mod Pathol. 2014;27:343–51.PubMedCrossRef Larque AB, Hakim S, Ordi J, et al. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Mod Pathol. 2014;27:343–51.PubMedCrossRef
35.
Zurück zum Zitat Laco J, Sieglova K, Vosmikova H, et al. The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis. Virchows Arch. 2015;467:405–15.PubMedCrossRef Laco J, Sieglova K, Vosmikova H, et al. The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis. Virchows Arch. 2015;467:405–15.PubMedCrossRef
36.
Zurück zum Zitat El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367–72.PubMedCrossRef El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367–72.PubMedCrossRef
37.
Zurück zum Zitat Alos L, Moyano S, Nadal A, et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer. 2009;115:2701–9.PubMedCrossRef Alos L, Moyano S, Nadal A, et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer. 2009;115:2701–9.PubMedCrossRef
38.
Zurück zum Zitat Chowdhury N, Alvi S, Kimura K, et al. Outcomes of HPV-related nasal squamous cell carcinoma. Laryngoscope. 2017;127:1600–3.PubMedCrossRef Chowdhury N, Alvi S, Kimura K, et al. Outcomes of HPV-related nasal squamous cell carcinoma. Laryngoscope. 2017;127:1600–3.PubMedCrossRef
39.
Zurück zum Zitat Jiromaru R, Yamamoto H, Yasumatsu R, et al. HPV-related sinonasal carcinoma: clinicopathologic features, diagnostic utility of p16 and Rb immunohistochemistry, and EGFR copy number alteration. Am J Surg Pathol. 2020;44:305–15.PubMedCrossRef Jiromaru R, Yamamoto H, Yasumatsu R, et al. HPV-related sinonasal carcinoma: clinicopathologic features, diagnostic utility of p16 and Rb immunohistochemistry, and EGFR copy number alteration. Am J Surg Pathol. 2020;44:305–15.PubMedCrossRef
40.
Zurück zum Zitat Bishop JA, Gagan J, Paterson C, McLellan D, Sandison A. Nonkeratinizing squamous cell carcinoma of the sinonasal tract with DEK-AFF2: further solidifying an emerging entity. Am J Surg Pathol. 2021;45:718–20.PubMedCrossRef Bishop JA, Gagan J, Paterson C, McLellan D, Sandison A. Nonkeratinizing squamous cell carcinoma of the sinonasal tract with DEK-AFF2: further solidifying an emerging entity. Am J Surg Pathol. 2021;45:718–20.PubMedCrossRef
41.
Zurück zum Zitat Rooper LM, Agaimy A, Dickson BC, et al. DEK-AFF2 carcinoma of the sinonasal region and skull base: detailed clinicopathologic characterization of a distinctive entity. Am J Surg Pathol. 2021;45:1682–93.PubMedCrossRef Rooper LM, Agaimy A, Dickson BC, et al. DEK-AFF2 carcinoma of the sinonasal region and skull base: detailed clinicopathologic characterization of a distinctive entity. Am J Surg Pathol. 2021;45:1682–93.PubMedCrossRef
42.
Zurück zum Zitat Kuo YJ, Lewis JS Jr, Zhai C, et al. DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology. Mod Pathol. 2021;34:1820–30.PubMedCrossRef Kuo YJ, Lewis JS Jr, Zhai C, et al. DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology. Mod Pathol. 2021;34:1820–30.PubMedCrossRef
43.
Zurück zum Zitat Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32:828–34.PubMedCrossRef Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32:828–34.PubMedCrossRef
44.
Zurück zum Zitat Lee T, Cho J, Baek CH, et al. Prevalence of NUT carcinoma in head and neck: analysis of 362 cases with literature review. Head Neck. 2020;42:924–38.PubMedCrossRef Lee T, Cho J, Baek CH, et al. Prevalence of NUT carcinoma in head and neck: analysis of 362 cases with literature review. Head Neck. 2020;42:924–38.PubMedCrossRef
45.
Zurück zum Zitat French CA, Rahman S, Walsh EM, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4:928–41.PubMedPubMedCentralCrossRef French CA, Rahman S, Walsh EM, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4:928–41.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Alekseyenko AA, Walsh EM, Zee BM, et al. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci USA. 2017;114:E4184–92.PubMedPubMedCentralCrossRef Alekseyenko AA, Walsh EM, Zee BM, et al. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci USA. 2017;114:E4184–92.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Shiota H, Elya JE, Alekseyenko AA, et al. “Z4” complex member fusions in NUT carcinoma: implications for a novel oncogenic mechanism. Mol Cancer Res. 2018;16:1826–33.PubMedPubMedCentralCrossRef Shiota H, Elya JE, Alekseyenko AA, et al. “Z4” complex member fusions in NUT carcinoma: implications for a novel oncogenic mechanism. Mol Cancer Res. 2018;16:1826–33.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Wang R, Liu W, Helfer CM, et al. Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma. Cancer Res. 2014;74:3332–43.PubMedPubMedCentralCrossRef Wang R, Liu W, Helfer CM, et al. Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma. Cancer Res. 2014;74:3332–43.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Chau NG, Ma C, Danga K, et al. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients. JNCI Cancer Spectr. 2020;4:94.CrossRef Chau NG, Ma C, Danga K, et al. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients. JNCI Cancer Spectr. 2020;4:94.CrossRef
50.
Zurück zum Zitat Tilson MP, Bishop JA. Utility of p40 in the differential diagnosis of small round blue cell tumors of the sinonasal tract. Head Neck Pathol. 2014;8:141–5.PubMedCrossRef Tilson MP, Bishop JA. Utility of p40 in the differential diagnosis of small round blue cell tumors of the sinonasal tract. Head Neck Pathol. 2014;8:141–5.PubMedCrossRef
51.
Zurück zum Zitat Matsuda K, Kashima J, Yatabe Y. The isoform matters in NUT carcinoma: a diagnostic pitfall of p40 immunohistochemistry. J Thorac Oncol. 2020;15:e176–8.PubMedCrossRef Matsuda K, Kashima J, Yatabe Y. The isoform matters in NUT carcinoma: a diagnostic pitfall of p40 immunohistochemistry. J Thorac Oncol. 2020;15:e176–8.PubMedCrossRef
54.
Zurück zum Zitat Agaimy A, Koch M, Lell M, et al. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol. 2014;38:1274–81.PubMedPubMedCentralCrossRef Agaimy A, Koch M, Lell M, et al. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol. 2014;38:1274–81.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Shah AA, Jain D, Ababneh E, et al. SMARCB1 (INI-1)-deficient adenocarcinoma of the sinonasal tract: a potentially under-recognized form of sinonasal adenocarcinoma with occasional yolk sac tumor-like features. Head Neck Pathol. 2019;14:465.PubMedPubMedCentralCrossRef Shah AA, Jain D, Ababneh E, et al. SMARCB1 (INI-1)-deficient adenocarcinoma of the sinonasal tract: a potentially under-recognized form of sinonasal adenocarcinoma with occasional yolk sac tumor-like features. Head Neck Pathol. 2019;14:465.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Agaimy A, Hartmann A, Antonescu CR, et al. SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity. Am J Surg Pathol. 2017;41:458–71.PubMedPubMedCentralCrossRef Agaimy A, Hartmann A, Antonescu CR, et al. SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity. Am J Surg Pathol. 2017;41:458–71.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Agaimy A, Jain D, Uddin N, Rooper LM, Bishop JA. SMARCA4-deficient sinonasal carcinoma: a series of 10 cases expanding the genetic spectrum of SWI/SNF-driven sinonasal malignancies. Am J Surg Pathol. 2020;44:703–10.PubMedCrossRef Agaimy A, Jain D, Uddin N, Rooper LM, Bishop JA. SMARCA4-deficient sinonasal carcinoma: a series of 10 cases expanding the genetic spectrum of SWI/SNF-driven sinonasal malignancies. Am J Surg Pathol. 2020;44:703–10.PubMedCrossRef
58.
Zurück zum Zitat Zong Y, Liu K, Zhong B, Chen G, Wu W. Epstein-Barr virus infection of sinonasal lymphoepithelial carcinoma in Guangzhou. Chin Med J (Engl). 2001;114:132–6. Zong Y, Liu K, Zhong B, Chen G, Wu W. Epstein-Barr virus infection of sinonasal lymphoepithelial carcinoma in Guangzhou. Chin Med J (Engl). 2001;114:132–6.
59.
Zurück zum Zitat Jeng YM, Sung MT, Fang CL, et al. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol. 2002;26:371–6.PubMedCrossRef Jeng YM, Sung MT, Fang CL, et al. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol. 2002;26:371–6.PubMedCrossRef
60.
Zurück zum Zitat Wenig BM. Lymphoepithelial-like carcinomas of the head and neck. Semin Diagn Pathol. 2015;32:74–86.PubMedCrossRef Wenig BM. Lymphoepithelial-like carcinomas of the head and neck. Semin Diagn Pathol. 2015;32:74–86.PubMedCrossRef
61.
Zurück zum Zitat Rytkonen AE, Hirvikoski PP, Salo TA. Lymphoepithelial carcinoma: two case reports and a systematic review of oral and sinonasal cases. Head Neck Pathol. 2011;5:327–34.PubMedPubMedCentralCrossRef Rytkonen AE, Hirvikoski PP, Salo TA. Lymphoepithelial carcinoma: two case reports and a systematic review of oral and sinonasal cases. Head Neck Pathol. 2011;5:327–34.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Reiersen DA, Pahilan ME, Devaiah AK. Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg. 2012;147:7–14.PubMedCrossRef Reiersen DA, Pahilan ME, Devaiah AK. Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg. 2012;147:7–14.PubMedCrossRef
63.
Zurück zum Zitat Xu CC, Dziegielewski PT, McGaw WT, Seikaly H. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review. J Otolaryngol Head Neck Surg. 2013;42:2.PubMedPubMedCentralCrossRef Xu CC, Dziegielewski PT, McGaw WT, Seikaly H. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review. J Otolaryngol Head Neck Surg. 2013;42:2.PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Dogan S, Chute DJ, Xu B, et al. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. J Pathol. 2017;242:400–8.PubMedPubMedCentralCrossRef Dogan S, Chute DJ, Xu B, et al. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. J Pathol. 2017;242:400–8.PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat Jo VY, Chau NG, Hornick JL, Krane JF, Sholl LM. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma. Mod Pathol. 2017;30:650–9.PubMedCrossRef Jo VY, Chau NG, Hornick JL, Krane JF, Sholl LM. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma. Mod Pathol. 2017;30:650–9.PubMedCrossRef
66.
Zurück zum Zitat Mito JK, Bishop JA, Sadow PM, et al. Immunohistochemical detection and molecular characterization of IDH-mutant sinonasal undifferentiated carcinomas. Am J Surg Pathol. 2018;42:1067–75.PubMedCrossRef Mito JK, Bishop JA, Sadow PM, et al. Immunohistochemical detection and molecular characterization of IDH-mutant sinonasal undifferentiated carcinomas. Am J Surg Pathol. 2018;42:1067–75.PubMedCrossRef
67.
Zurück zum Zitat Riobello C, Lopez-Hernandez A, Cabal VN, et al. IDH2 mutation analysis in undifferentiated and poorly differentiated sinonasal carcinomas for diagnosis and clinical management. Am J Surg Pathol. 2020;44:396–405.PubMedCrossRef Riobello C, Lopez-Hernandez A, Cabal VN, et al. IDH2 mutation analysis in undifferentiated and poorly differentiated sinonasal carcinomas for diagnosis and clinical management. Am J Surg Pathol. 2020;44:396–405.PubMedCrossRef
68.
Zurück zum Zitat Birkeland AC, Burgin SJ, Yanik M, et al. Pathogenetic analysis of sinonasal teratocarcinosarcomas reveal actionable beta-catenin overexpression and a beta-catenin mutation. J Neurol Surg B Skull Base. 2017;78:346–52.PubMedPubMedCentralCrossRef Birkeland AC, Burgin SJ, Yanik M, et al. Pathogenetic analysis of sinonasal teratocarcinosarcomas reveal actionable beta-catenin overexpression and a beta-catenin mutation. J Neurol Surg B Skull Base. 2017;78:346–52.PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Rooper LM, Uddin N, Gagan J, et al. Recurrent loss of SMARCA4 in sinonasal teratocarcinosarcoma. Am J Surg Pathol. 2020;44:1331–9.PubMedCrossRef Rooper LM, Uddin N, Gagan J, et al. Recurrent loss of SMARCA4 in sinonasal teratocarcinosarcoma. Am J Surg Pathol. 2020;44:1331–9.PubMedCrossRef
70.
Zurück zum Zitat Bishop JA, Andreasen S, Hang JF, et al. HPV-related multiphenotypic sinonasal carcinoma: an expanded series of 49 cases of the tumor formerly known as HPV-related carcinoma with adenoid cystic carcinoma-like features. Am J Surg Pathol. 2017;41:1690–701.PubMedPubMedCentralCrossRef Bishop JA, Andreasen S, Hang JF, et al. HPV-related multiphenotypic sinonasal carcinoma: an expanded series of 49 cases of the tumor formerly known as HPV-related carcinoma with adenoid cystic carcinoma-like features. Am J Surg Pathol. 2017;41:1690–701.PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Bishop JA, Ogawa T, Stelow EB, et al. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol. 2013;37:836–44.PubMedPubMedCentralCrossRef Bishop JA, Ogawa T, Stelow EB, et al. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol. 2013;37:836–44.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Bishop JA, Westra WH. Human papillomavirus-related multiphenotypic sinonasal carcinoma: an emerging tumor type with a unique microscopic appearance and a paradoxical clinical behaviour. Oral Oncol. 2018;87:17–20.PubMedCrossRef Bishop JA, Westra WH. Human papillomavirus-related multiphenotypic sinonasal carcinoma: an emerging tumor type with a unique microscopic appearance and a paradoxical clinical behaviour. Oral Oncol. 2018;87:17–20.PubMedCrossRef
73.
Zurück zum Zitat Rooper LM, McCuiston AM, Westra WH, Bishop JA. SOX10 immunoexpression in basaloid squamous cell carcinomas: a diagnostic pitfall for ruling out salivary differentiation. Head Neck Pathol. 2018;13:543–7.PubMedPubMedCentralCrossRef Rooper LM, McCuiston AM, Westra WH, Bishop JA. SOX10 immunoexpression in basaloid squamous cell carcinomas: a diagnostic pitfall for ruling out salivary differentiation. Head Neck Pathol. 2018;13:543–7.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Antony VM, Kakkar A, Sikka K, et al. p16 Immunoexpression in sinonasal and nasopharyngeal adenoid cystic carcinomas: a potential pitfall in ruling out HPV-related multiphenotypic sinonasal carcinoma. Histopathology. 2020;77:989–93.PubMedCrossRef Antony VM, Kakkar A, Sikka K, et al. p16 Immunoexpression in sinonasal and nasopharyngeal adenoid cystic carcinomas: a potential pitfall in ruling out HPV-related multiphenotypic sinonasal carcinoma. Histopathology. 2020;77:989–93.PubMedCrossRef
75.
Zurück zum Zitat Choussy O, Ferron C, Vedrine PO, et al. Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases. Laryngoscope. 2008;118:437–43.PubMedCrossRef Choussy O, Ferron C, Vedrine PO, et al. Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases. Laryngoscope. 2008;118:437–43.PubMedCrossRef
76.
Zurück zum Zitat Donhuijsen K, Kollecker I, Petersen P, Gassler N, Wolf J, Schroeder HG. Clinical and morphological aspects of adenocarcinomas of the intestinal type in the inner nose: a retrospective multicenter analysis. Eur Arch Otorhinolaryngol. 2016;273:3207–13.PubMedCrossRef Donhuijsen K, Kollecker I, Petersen P, Gassler N, Wolf J, Schroeder HG. Clinical and morphological aspects of adenocarcinomas of the intestinal type in the inner nose: a retrospective multicenter analysis. Eur Arch Otorhinolaryngol. 2016;273:3207–13.PubMedCrossRef
77.
Zurück zum Zitat Fiaux-Camous D, Chevret S, Oker N, et al. Prognostic value of the seventh AJCC/UICC TNM classification of intestinal-type ethmoid adenocarcinoma: systematic review and risk prediction model. Head Neck. 2017;39:668–78.PubMedCrossRef Fiaux-Camous D, Chevret S, Oker N, et al. Prognostic value of the seventh AJCC/UICC TNM classification of intestinal-type ethmoid adenocarcinoma: systematic review and risk prediction model. Head Neck. 2017;39:668–78.PubMedCrossRef
78.
Zurück zum Zitat Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 1986;10:192–202.PubMedCrossRef Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 1986;10:192–202.PubMedCrossRef
79.
Zurück zum Zitat Franchi A, Massi D, Palomba A, Biancalani M, Santucci M. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Virchows Arch. 2004;445:63–7.PubMed Franchi A, Massi D, Palomba A, Biancalani M, Santucci M. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Virchows Arch. 2004;445:63–7.PubMed
80.
Zurück zum Zitat Kennedy MT, Jordan RC, Berean KW, Perez-Ordonez B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol. 2004;57:932–7.PubMedPubMedCentralCrossRef Kennedy MT, Jordan RC, Berean KW, Perez-Ordonez B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol. 2004;57:932–7.PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Sjostedt S, Schmidt AY, Vieira FG, et al. Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma. J Cancer Res Clin Oncol. 2021;147:1019–27.PubMedCrossRef Sjostedt S, Schmidt AY, Vieira FG, et al. Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma. J Cancer Res Clin Oncol. 2021;147:1019–27.PubMedCrossRef
82.
Zurück zum Zitat Perrone F, Oggionni M, Birindelli S, et al. TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Int J Cancer. 2003;105:196–203.PubMedCrossRef Perrone F, Oggionni M, Birindelli S, et al. TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Int J Cancer. 2003;105:196–203.PubMedCrossRef
83.
Zurück zum Zitat Holmila R, Bornholdt J, Heikkila P, et al. Mutations in TP53 tumor suppressor gene in wood dust-related sinonasal cancer. Int J Cancer. 2010;127:578–88.PubMedCrossRef Holmila R, Bornholdt J, Heikkila P, et al. Mutations in TP53 tumor suppressor gene in wood dust-related sinonasal cancer. Int J Cancer. 2010;127:578–88.PubMedCrossRef
84.
Zurück zum Zitat Perez-Escuredo J, Martinez JG, Vivanco B, et al. Wood dust-related mutational profile of TP53 in intestinal-type sinonasal adenocarcinoma. Hum Pathol. 2012;43:1894–901.PubMedCrossRef Perez-Escuredo J, Martinez JG, Vivanco B, et al. Wood dust-related mutational profile of TP53 in intestinal-type sinonasal adenocarcinoma. Hum Pathol. 2012;43:1894–901.PubMedCrossRef
85.
Zurück zum Zitat Garcia-Inclan C, Lopez F, Perez-Escuredo J, et al. EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas. Cell Oncol (Dordr). 2012;35:443–50.CrossRef Garcia-Inclan C, Lopez F, Perez-Escuredo J, et al. EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas. Cell Oncol (Dordr). 2012;35:443–50.CrossRef
86.
Zurück zum Zitat Lopez F, Garcia Inclan C, Perez-Escuredo J, et al. KRAS and BRAF mutations in sinonasal cancer. Oral Oncol. 2012;48:692–7.PubMedCrossRef Lopez F, Garcia Inclan C, Perez-Escuredo J, et al. KRAS and BRAF mutations in sinonasal cancer. Oral Oncol. 2012;48:692–7.PubMedCrossRef
87.
Zurück zum Zitat Franchi A, Innocenti DR, Palomba A, et al. Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments. Pathol Oncol Res. 2014;20:571–9.PubMedCrossRef Franchi A, Innocenti DR, Palomba A, et al. Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments. Pathol Oncol Res. 2014;20:571–9.PubMedCrossRef
88.
Zurück zum Zitat Heffner DK, Hyams VJ, Hauck KW, Lingeman C. Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer. 1982;50:312–22.PubMedCrossRef Heffner DK, Hyams VJ, Hauck KW, Lingeman C. Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer. 1982;50:312–22.PubMedCrossRef
89.
Zurück zum Zitat Neto AG, Pineda-Daboin K, Luna MA. Sinonasal tract seromucous adenocarcinomas: a report of 12 cases. Ann Diagn Pathol. 2003;7:154–9.PubMedCrossRef Neto AG, Pineda-Daboin K, Luna MA. Sinonasal tract seromucous adenocarcinomas: a report of 12 cases. Ann Diagn Pathol. 2003;7:154–9.PubMedCrossRef
90.
Zurück zum Zitat Skalova A, Cardesa A, Leivo I, et al. Sinonasal tubulopapillary low-grade adenocarcinoma. Histopathological, immunohistochemical and ultrastructural features of poorly recognised entity. Virchows Arch. 2003;443:152–8.PubMedCrossRef Skalova A, Cardesa A, Leivo I, et al. Sinonasal tubulopapillary low-grade adenocarcinoma. Histopathological, immunohistochemical and ultrastructural features of poorly recognised entity. Virchows Arch. 2003;443:152–8.PubMedCrossRef
91.
Zurück zum Zitat Storck K, Hadi UM, Simpson R, Ramer M, Brandwein-Gensler M. Sinonasal renal cell-like adenocarcinoma: a report on four patients. Head Neck Pathol. 2008;2:75–80.PubMedPubMedCentralCrossRef Storck K, Hadi UM, Simpson R, Ramer M, Brandwein-Gensler M. Sinonasal renal cell-like adenocarcinoma: a report on four patients. Head Neck Pathol. 2008;2:75–80.PubMedPubMedCentralCrossRef
92.
Zurück zum Zitat Shen T, Shi Q, Velosa C, et al. Sinonasal renal cell-like adenocarcinomas: robust carbonic anhydrase expression. Hum Pathol. 2015;46:1598–606.PubMedCrossRef Shen T, Shi Q, Velosa C, et al. Sinonasal renal cell-like adenocarcinomas: robust carbonic anhydrase expression. Hum Pathol. 2015;46:1598–606.PubMedCrossRef
93.
Zurück zum Zitat Stelow EB, Jo VY, Mills SE, Carlson DL. A histologic and immunohistochemical study describing the diversity of tumors classified as sinonasal high-grade nonintestinal adenocarcinomas. Am J Surg Pathol. 2011;35:971–80.PubMedCrossRef Stelow EB, Jo VY, Mills SE, Carlson DL. A histologic and immunohistochemical study describing the diversity of tumors classified as sinonasal high-grade nonintestinal adenocarcinomas. Am J Surg Pathol. 2011;35:971–80.PubMedCrossRef
94.
Zurück zum Zitat Purgina B, Bastaki JM, Duvvuri U, Seethala RR. A subset of sinonasal non-intestinal type adenocarcinomas are truly seromucinous adenocarcinomas: a morphologic and immunophenotypic assessment and description of a novel pitfall. Head Neck Pathol. 2015;9:436–46.PubMedPubMedCentralCrossRef Purgina B, Bastaki JM, Duvvuri U, Seethala RR. A subset of sinonasal non-intestinal type adenocarcinomas are truly seromucinous adenocarcinomas: a morphologic and immunophenotypic assessment and description of a novel pitfall. Head Neck Pathol. 2015;9:436–46.PubMedPubMedCentralCrossRef
95.
Zurück zum Zitat Andreasen S, Skalova A, Agaimy A, et al. ETV6 gene rearrangements characterize a morphologically distinct subset of sinonasal low-grade non-intestinal-type adenocarcinoma: a novel translocation-associated carcinoma restricted to the sinonasal tract. Am J Surg Pathol. 2017;41:1552–60.PubMedCrossRef Andreasen S, Skalova A, Agaimy A, et al. ETV6 gene rearrangements characterize a morphologically distinct subset of sinonasal low-grade non-intestinal-type adenocarcinoma: a novel translocation-associated carcinoma restricted to the sinonasal tract. Am J Surg Pathol. 2017;41:1552–60.PubMedCrossRef
96.
Zurück zum Zitat Villatoro TM, Mardekian SK. Two cases of sinonasal non-intestinal-type adenocarcinoma with squamoid morules expressing nuclear beta-catenin and CDX2: a curious morphologic finding supported by molecular analysis. Case Rep Pathol. 2018;2018:8741017.PubMedPubMedCentral Villatoro TM, Mardekian SK. Two cases of sinonasal non-intestinal-type adenocarcinoma with squamoid morules expressing nuclear beta-catenin and CDX2: a curious morphologic finding supported by molecular analysis. Case Rep Pathol. 2018;2018:8741017.PubMedPubMedCentral
97.
Zurück zum Zitat Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol. 2001;158:1073–8.PubMedPubMedCentralCrossRef Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol. 2001;158:1073–8.PubMedPubMedCentralCrossRef
98.
Zurück zum Zitat Sanchez-Romero C, Carlos R, Diaz Molina JP, Thompson LDR, de Almeida OP, Rumayor PA. Nasopharyngeal angiofibroma: a clinical, histopathological and immunohistochemical study of 42 cases with emphasis on stromal features. Head Neck Pathol. 2018;12:52–61.PubMedCrossRef Sanchez-Romero C, Carlos R, Diaz Molina JP, Thompson LDR, de Almeida OP, Rumayor PA. Nasopharyngeal angiofibroma: a clinical, histopathological and immunohistochemical study of 42 cases with emphasis on stromal features. Head Neck Pathol. 2018;12:52–61.PubMedCrossRef
99.
Zurück zum Zitat Carlos R, Thompson LD, Netto AC, et al. Epstein-Barr virus and human herpes virus-8 are not associated with juvenile nasopharyngeal angiofibroma. Head Neck Pathol. 2008;2:145–9.PubMedPubMedCentralCrossRef Carlos R, Thompson LD, Netto AC, et al. Epstein-Barr virus and human herpes virus-8 are not associated with juvenile nasopharyngeal angiofibroma. Head Neck Pathol. 2008;2:145–9.PubMedPubMedCentralCrossRef
100.
Zurück zum Zitat Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11:1122–6.PubMed Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11:1122–6.PubMed
101.
Zurück zum Zitat Lasota J, Felisiak-Golabek A, Aly FZ, Wang ZF, Thompson LD, Miettinen M. Nuclear expression and gain-of-function beta-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker. Mod Pathol. 2015;28:715–20.PubMedCrossRef Lasota J, Felisiak-Golabek A, Aly FZ, Wang ZF, Thompson LD, Miettinen M. Nuclear expression and gain-of-function beta-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker. Mod Pathol. 2015;28:715–20.PubMedCrossRef
102.
Zurück zum Zitat Haller F, Bieg M, Moskalev EA, et al. Recurrent mutations within the amino-terminal region of beta-catenin are probable key molecular driver events in sinonasal hemangiopericytoma. Am J Pathol. 2015;185:563–71.PubMedCrossRef Haller F, Bieg M, Moskalev EA, et al. Recurrent mutations within the amino-terminal region of beta-catenin are probable key molecular driver events in sinonasal hemangiopericytoma. Am J Pathol. 2015;185:563–71.PubMedCrossRef
103.
Zurück zum Zitat Suzuki Y, Ichihara S, Kawasaki T, et al. beta-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma). Virchows Arch. 2018;473:235–9.PubMedCrossRef Suzuki Y, Ichihara S, Kawasaki T, et al. beta-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma). Virchows Arch. 2018;473:235–9.PubMedCrossRef
104.
Zurück zum Zitat Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003;27:737–49.PubMedCrossRef Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003;27:737–49.PubMedCrossRef
105.
Zurück zum Zitat Sangoi AR, Bishop JA. Variability of CD34 expression in sinonasal glomangiopericytoma: a potential diagnostic pitfall. Head Neck Pathol. 2020;14:459–64.PubMedCrossRef Sangoi AR, Bishop JA. Variability of CD34 expression in sinonasal glomangiopericytoma: a potential diagnostic pitfall. Head Neck Pathol. 2020;14:459–64.PubMedCrossRef
106.
Zurück zum Zitat Cottone L, Eden N, Usher I, et al. Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma. J Pathol Clin Res. 2020;6:113–23.PubMedPubMedCentralCrossRef Cottone L, Eden N, Usher I, et al. Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma. J Pathol Clin Res. 2020;6:113–23.PubMedPubMedCentralCrossRef
107.
Zurück zum Zitat Bai J, Shi J, Li C, et al. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival. Nat Commun. 2021;12:757.PubMedPubMedCentralCrossRef Bai J, Shi J, Li C, et al. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival. Nat Commun. 2021;12:757.PubMedPubMedCentralCrossRef
108.
Zurück zum Zitat Hasselblatt M, Thomas C, Hovestadt V, et al. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis. Acta Neuropathol. 2016;132:149–51.PubMedCrossRef Hasselblatt M, Thomas C, Hovestadt V, et al. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis. Acta Neuropathol. 2016;132:149–51.PubMedCrossRef
109.
Zurück zum Zitat Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209:157–65.PubMedCrossRef Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209:157–65.PubMedCrossRef
110.
Zurück zum Zitat Jo VY, Hornick JL, Qian X. Utility of brachyury in distinction of chordoma from cytomorphologic mimics in fine-needle aspiration and core needle biopsy. Diagn Cytopathol. 2014;42:647–52.PubMedCrossRef Jo VY, Hornick JL, Qian X. Utility of brachyury in distinction of chordoma from cytomorphologic mimics in fine-needle aspiration and core needle biopsy. Diagn Cytopathol. 2014;42:647–52.PubMedCrossRef
111.
Zurück zum Zitat Schafer DR, Thompson LD, Smith BC, Wenig BM. Primary ameloblastoma of the sinonasal tract: a clinicopathologic study of 24 cases. Cancer. 1998;82:667–74.PubMedCrossRef Schafer DR, Thompson LD, Smith BC, Wenig BM. Primary ameloblastoma of the sinonasal tract: a clinicopathologic study of 24 cases. Cancer. 1998;82:667–74.PubMedCrossRef
113.
Zurück zum Zitat Brown NA, Rolland D, McHugh JB, et al. Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20:5517–26.PubMedCrossRef Brown NA, Rolland D, McHugh JB, et al. Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20:5517–26.PubMedCrossRef
114.
Zurück zum Zitat Momota H, Ichimiya S, Ikeda T, et al. Immunohistochemical analysis of the p53 family members in human craniopharyngiomas. Brain Tumor Pathol. 2003;20:73–7.PubMedCrossRef Momota H, Ichimiya S, Ikeda T, et al. Immunohistochemical analysis of the p53 family members in human craniopharyngiomas. Brain Tumor Pathol. 2003;20:73–7.PubMedCrossRef
115.
Zurück zum Zitat Xin W, Rubin MA, McKeever PE. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst. Arch Pathol Lab Med. 2002;126:1174–8.PubMedCrossRef Xin W, Rubin MA, McKeever PE. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst. Arch Pathol Lab Med. 2002;126:1174–8.PubMedCrossRef
116.
Zurück zum Zitat Thimsen V, John N, Buchfelder M, et al. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in craniopharyngioma subtypes and surrounding brain tissue. Sci Rep. 2017;7:15856.PubMedPubMedCentralCrossRef Thimsen V, John N, Buchfelder M, et al. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in craniopharyngioma subtypes and surrounding brain tissue. Sci Rep. 2017;7:15856.PubMedPubMedCentralCrossRef
117.
Zurück zum Zitat Buslei R, Holsken A, Hofmann B, et al. Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol. 2007;113:585–90.PubMedCrossRef Buslei R, Holsken A, Hofmann B, et al. Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol. 2007;113:585–90.PubMedCrossRef
118.
Zurück zum Zitat Goschzik T, Gessi M, Dreschmann V, et al. Genomic alterations of adamantinomatous and papillary craniopharyngioma. J Neuropathol Exp Neurol. 2017;76:126–34.PubMed Goschzik T, Gessi M, Dreschmann V, et al. Genomic alterations of adamantinomatous and papillary craniopharyngioma. J Neuropathol Exp Neurol. 2017;76:126–34.PubMed
119.
Zurück zum Zitat Apps JR, Stache C, Gonzalez-Meljem JM, et al. CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma. Neuropathol Appl Neurobiol. 2020;46:510–4.PubMedPubMedCentralCrossRef Apps JR, Stache C, Gonzalez-Meljem JM, et al. CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma. Neuropathol Appl Neurobiol. 2020;46:510–4.PubMedPubMedCentralCrossRef
120.
Zurück zum Zitat Beaty NB, Ahn E. Images in clinical medicine. Adamantinomatous craniopharyngioma containing teeth. N Engl J Med. 2014;370:860.PubMedCrossRef Beaty NB, Ahn E. Images in clinical medicine. Adamantinomatous craniopharyngioma containing teeth. N Engl J Med. 2014;370:860.PubMedCrossRef
121.
Zurück zum Zitat Thompson LD, Gyure KA. Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol. 2000;24:640–50.PubMedCrossRef Thompson LD, Gyure KA. Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol. 2000;24:640–50.PubMedCrossRef
122.
123.
Zurück zum Zitat Liu Y, Wang H, Shao H, Wang C. Primary extradural meningiomas in head: a report of 19 cases and review of literature. Int J Clin Exp Pathol. 2015;8:5624–32.PubMedPubMedCentral Liu Y, Wang H, Shao H, Wang C. Primary extradural meningiomas in head: a report of 19 cases and review of literature. Int J Clin Exp Pathol. 2015;8:5624–32.PubMedPubMedCentral
124.
Zurück zum Zitat Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T. Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathol. 2015;130:441–3.PubMedCrossRef Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T. Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathol. 2015;130:441–3.PubMedCrossRef
125.
Zurück zum Zitat Silva CB, Ongaratti BR, Trott G, et al. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance. Int J Clin Exp Pathol. 2015;8:13185–92.PubMedPubMedCentral Silva CB, Ongaratti BR, Trott G, et al. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance. Int J Clin Exp Pathol. 2015;8:13185–92.PubMedPubMedCentral
127.
Zurück zum Zitat Cleary JO, Yeung J, McMeekin H, Wilhelm T, Wagner T. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients. Nucl Med Commun. 2016;37:1197–205.PubMedCrossRef Cleary JO, Yeung J, McMeekin H, Wilhelm T, Wagner T. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients. Nucl Med Commun. 2016;37:1197–205.PubMedCrossRef
128.
Zurück zum Zitat Parghane RV, Talole S, Basu S. Prevalence of hitherto unknown brain meningioma detected on (68)Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of (177)Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors. World J Nucl Med. 2019;18:160–70.PubMedPubMedCentralCrossRef Parghane RV, Talole S, Basu S. Prevalence of hitherto unknown brain meningioma detected on (68)Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of (177)Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors. World J Nucl Med. 2019;18:160–70.PubMedPubMedCentralCrossRef
129.
Zurück zum Zitat Juratli TA, Thiede C, Koerner MVA, et al. Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas. Oncotarget. 2017;8:109228–37.PubMedPubMedCentralCrossRef Juratli TA, Thiede C, Koerner MVA, et al. Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas. Oncotarget. 2017;8:109228–37.PubMedPubMedCentralCrossRef
130.
Zurück zum Zitat Mirian C, Duun-Henriksen AK, Juratli T, et al. Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. J Neurol Neurosurg Psychiatry. 2020;91:378–87.PubMedCrossRef Mirian C, Duun-Henriksen AK, Juratli T, et al. Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. J Neurol Neurosurg Psychiatry. 2020;91:378–87.PubMedCrossRef
131.
Zurück zum Zitat Rostomily RC, Elias M, Deng M, et al. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression. Head Neck. 2006;28:305–12.PubMedCrossRef Rostomily RC, Elias M, Deng M, et al. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression. Head Neck. 2006;28:305–12.PubMedCrossRef
132.
Zurück zum Zitat Hasan OK, Ravi Kumar AS, Kong G, et al. Efficacy of peptide receptor radionuclide therapy for esthesioneuroblastoma. J Nucl Med. 2020;61:1326–30.PubMedCrossRef Hasan OK, Ravi Kumar AS, Kong G, et al. Efficacy of peptide receptor radionuclide therapy for esthesioneuroblastoma. J Nucl Med. 2020;61:1326–30.PubMedCrossRef
133.
Zurück zum Zitat Gains JE, Aldridge MD, Mattoli MV, et al. 68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy. Nucl Med Commun. 2020;41:1169–77.PubMedCrossRef Gains JE, Aldridge MD, Mattoli MV, et al. 68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy. Nucl Med Commun. 2020;41:1169–77.PubMedCrossRef
134.
Zurück zum Zitat Cracolici V, Wang EW, Gardner PA, et al. SSTR2 expression in olfactory neuroblastoma: Clin. Head Neck Pathol. 2021;15:1185–91.PubMedCrossRef Cracolici V, Wang EW, Gardner PA, et al. SSTR2 expression in olfactory neuroblastoma: Clin. Head Neck Pathol. 2021;15:1185–91.PubMedCrossRef
135.
Zurück zum Zitat Gallagher KK, Spector ME, Pepper JP, McKean EL, Marentette LJ, McHugh JB. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis. Ann Otol Rhinol Laryngol. 2014;123:353–8.PubMedCrossRef Gallagher KK, Spector ME, Pepper JP, McKean EL, Marentette LJ, McHugh JB. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis. Ann Otol Rhinol Laryngol. 2014;123:353–8.PubMedCrossRef
136.
Zurück zum Zitat Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB. Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg. 2014;140:1124–9.PubMedCrossRef Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB. Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg. 2014;140:1124–9.PubMedCrossRef
137.
Zurück zum Zitat Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015;17:423.PubMedCrossRef Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015;17:423.PubMedCrossRef
139.
Zurück zum Zitat Holbrook EH, Wu E, Curry WT, Lin DT, Schwob JE. Immunohistochemical characterization of human olfactory tissue. Laryngoscope. 2011;121:1687–701.PubMedPubMedCentralCrossRef Holbrook EH, Wu E, Curry WT, Lin DT, Schwob JE. Immunohistochemical characterization of human olfactory tissue. Laryngoscope. 2011;121:1687–701.PubMedPubMedCentralCrossRef
140.
Zurück zum Zitat Bishop JA, Thompson LD, Cardesa A, et al. Rhabdomyoblastic differentiation in head and neck malignancies other than rhabdomyosarcoma. Head Neck Pathol. 2015;9:507–18.PubMedPubMedCentralCrossRef Bishop JA, Thompson LD, Cardesa A, et al. Rhabdomyoblastic differentiation in head and neck malignancies other than rhabdomyosarcoma. Head Neck Pathol. 2015;9:507–18.PubMedPubMedCentralCrossRef
141.
Zurück zum Zitat Thompson LD. Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach. Mod Pathol. 2017;30:S1–26.PubMedCrossRef Thompson LD. Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach. Mod Pathol. 2017;30:S1–26.PubMedCrossRef
Metadaten
Titel
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base
verfasst von
Lester D. R. Thompson
Justin A. Bishop
Publikationsdatum
21.03.2022
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2022
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-021-01406-5

Weitere Artikel der Ausgabe 1/2022

Head and Neck Pathology 1/2022 Zur Ausgabe

UPDATE FROM THE 5TH EDITION OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF HEAD AND NECK TUMORS

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Familial Tumor Syndromes

UPDATE FROM THE 5TH EDITION OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF HEAD AND NECK TUMORS

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hematolymphoid Proliferations and Neoplasia

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …